| Missing Links? Citation Matrix | Graphs | Glossary HistCite Guide About |
|
MELLIN GW, 1962, NEW ENGL J MED, V267, P1184 MELLIN GW, 1962, NEW ENGL J MED, V267, P1238 LENZ W, 1961, DEUT MED WOCHENSCHR, V86, P2555 LENZ W, 1962, DEUT MED WOCHENSCHR, V87, P1232 KUNZ W, 1956, ARZNEIMITTEL-FORSCH, V6, P426 SHESKIN J, 1965, LEPROSY REV, V36, P183 WIEDEMANN HR, 1961, MED WELT, V37, P1863 BECKMANN R, 1962, ARZNEIMITTEL-FORSCH, V12, P1095 |
Nodes: 2685,
Authors: 6203,
Journals: 662,
Outer References: 16023,
Words: 3995
Collection span: 1956 - 2004
View: Overview. Sorted by journal name.
Page 1: 1 2 3 4 5 6 7 8 9
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
|---|---|---|---|---|---|
| 1 | 0 | 0 | 740 1981 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 181(MAR):68-MEDI HASSAN KM; AGRAWAL KC; HASTINGS RC ANTI-INFLAMMATORY - IMMUNOSUPPRESSIVE THALIDOMIDE ANALOGS | 0 | 0 |
| 2 | 0 | 0 | 871 1985 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 189(APR-):21-MEDI KING BT; AGRAWAL KC; MORALES MJ; HASTINGS RC ANTIINFLAMMATORY IMMUNOSUPPRESSIVE THALIDOMIDE ANALOGS | 0 | 0 |
| 3 | 0 | 0 | 1081 1993 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 206:216-MEDI HE WX; ENGSTROM L; WALKER S; VOGELSANG G; LEONG KW SYNTHESIS OF THALIDOMIDE ANALOGS AND THEIR BIOLOGICAL POTENTIAL FOR TREATMENT OF GRAFT-VERSUS-HOST DISEASE | 0 | 0 |
| 4 | 0 | 0 | 1223 1996 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 212:140-MEDI Niwayama S; Turk B; Liu J Potent inhibition of tumor necrosis factor-alpha by tetrafluoro-thalidomide and tetrafluorophthalimides | 0 | 0 |
| 5 | 0 | 0 | 1391 1998 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 216:U267-U267 Swartz GM; Shah JH; Fogler WE; Papathanassiu A; Madsen JW; Green SJ 2-methyl-2-phthalimidino-glutaric acid, a partially-reduced analog of thalidomide, is a potent inhibitor of B16 melanoma metastases. | 0 | 0 |
| 6 | 0 | 0 | 1479 1999 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 217:U88-U88 Konnecke WE; Smith AM; Khetani VD A two step synthesis of thalidomide. | 0 | 0 |
| 7 | 0 | 0 | 1480 1999 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 218:U58-U58 Luzzio FA; Thomas EM; Figg WD Stereoselective synthesis of thalidomide analogs. | 0 | 0 |
| 8 | 0 | 0 | 1605 2000 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 219:U227-U227 Luzzio FA; Mayorov AV; Figg WD Thalidomide metabolites: Preparation of (+)-2-(N-phthalimido)- 4-hydroxyglutamic acid derivatives. | 0 | 0 |
| 9 | 0 | 0 | 1606 2000 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 220:U96-U96 Luzzio FA; Thomas EM; Figg WD Thalidomide analogs and metabolites: Cyclic and acyclic derivatives of 2S, 3S-2-N-phthalimido(3-hydroxy)ornithine. | 0 | 0 |
| 10 | 0 | 0 | 1798 2001 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 222:U653-U653 Shi JD; Xiao ZL; Marks M; Kamat C; Pokala V Development of thalidomide analogs as anti-angiogenic agents. | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 11 | 0 | 0 | 1799 2001 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 222:U659-U659 Xiao ZL; Schaefer K; Li PK Solid phase synthesis of thalidomide and its analogs. | 0 | 0 |
| 12 | 0 | 0 | 1800 2001 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 222:U685-U685 Luzzio FA; Figg WD; Mayorov AV; Kruger EA Thalidomide metabolites and analogs, part 3: Synthesis and antiangiogenic activity of the teratogenic and TNF-alpha-modulatory thalidomide analog EM-12. | 0 | 0 |
| 13 | 0 | 0 | 2015 2002 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 224:U21-U21 Hu ZG; Zink J; Zili X; Shi JD; Li PK Anti-angiogenic and anti-proliferative thalidomide analogs. | 0 | 0 |
| 14 | 0 | 0 | 2292 2003 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 225:U196-U197 Hu ZG; Pandit B; Shi JD; Zink J; Sackett DL; Li PK Thalidomide analogs with antiproliferative and antimicrotubule activities. | 0 | 0 |
| 15 | 0 | 0 | 2293 2003 ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 225:U197-U197 Luzzio FA; Ng SSW; Gutschow M; Hauschildt S; Weiss M; Teubert U; Kruger E; Mayorov AV; Eger K; Figg WD Antiangiogenic activity of N-substituted and tetrafluorinated thalidomide analogs. | 0 | 0 |
| 16 | 2 | 20 | 411 1967 ACTA ANATOMICA 66(2):226-& GIL DR INFLUENCE OF THALIDOMIDE ON DEVELOPMENT OF CHICK EMBRYOS CULTIVATED IN VITRO | 1 | 1 |
| 17 | 3 | 10 | 304 1965 ACTA CHEMICA SCANDINAVICA 19(5):1266-& FURBERG S STRUCTURAL RELATIONSHIP BETWEEN THALIDOMIDE AND NUCLEOSIDES | 8 | 13 |
| 18 | 6 | 20 | 771 1982 ACTA DERMATO-VENEREOLOGICA 62(4):321-324 HASPER MF; KLOKKE AH THALIDOMIDE IN THE TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS | 17 | 23 |
| 19 | 4 | 7 | 772 1982 ACTA DERMATO-VENEREOLOGICA 62(5):449-450 BAHMER FA; ZAUN H; LUSZPINSKI P THALIDOMIDE TREATMENT OF RECURRENT ERYTHEMA MULTIFORME | 19 | 25 |
| 20 | 8 | 13 | 839 1984 ACTA DERMATO-VENEREOLOGICA 64(5):412-417 WINKELMANN RK; CONNOLLY SM; DOYLE JA; PADILHAGONCALVES A THALIDOMIDE TREATMENT OF PRURIGO NODULARIS | 17 | 27 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 21 | 4 | 9 | 1607 2000 ACTA DERMATO-VENEREOLOGICA 80(1):24-25 Daly BM; Shuster S Antipruritic action of thalidomide | 3 | 9 |
| 22 | 6 | 15 | 2016 2002 ACTA DERMATO-VENEREOLOGICA 82(5):384-386 Kolde G; Schulze P; Sterry W Mixed response to thalidomide therapy in adults: Two cases of multisystem Langerhans' cell histiocytosis | 1 | 2 |
| 23 | 2 | 8 | 2294 2003 ACTA DERMATO-VENEREOLOGICA 83(4):302-303 Staumont-Salle D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide | 0 | 0 |
| 24 | 14 | 33 | 1002 1990 ACTA ENDOCRINOLOGICA 123(1):79-83 LUEPRASITSAKUL W; ABEND S; ALEX S; REINHARDT W; APPEL MC; BRAVERMAN LE EFFECT OF THALIDOMIDE ON THE INCIDENCE OF IODINE-INDUCED AND SPONTANEOUS LYMPHOCYTIC THYROIDITIS AND SPONTANEOUS DIABETES-MELLITUS IN THE BB/WOR RAT | 2 | 2 |
| 25 | 0 | 5 | 444 1968 ACTA ENTOMOLOGICA BOHEMOSLOVACA 65(3):212-& REZABOVA B; LANDA V EFFECTS OF THALIDOMIDE ON DEVELOPMENT OF HOUSE FLY MUSCA DOMESTICA L | 0 | 8 |
| 26 | 0 | 31 | 492 1970 ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 19(1-2):205-& JORGENSE.G; LENZ W; PFEIFFER RA; SCHAAFHA.C THALIDOMIDE-EMBRYOPATHY IN TWINS - A COLLABORATIVE STUDY | 0 | 15 |
| 27 | 2 | 3 | 716 1980 ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE 29(4):295-297 SCHMIDT M; SALZANO FM DISSIMILAR EFFECTS OF THALIDOMIDE IN DIZYGOTIC TWINS | 1 | 8 |
| 28 | 5 | 9 | 2295 2003 ACTA HAEMATOLOGICA 109(3):153-155 Tsiara S; Chaidos A; Kapsali H; Tzouvara E; Bourantas KL Thalidomide administration for the treatment of resistant plasma cell leukemia | 0 | 0 |
| 29 | 1 | 10 | 305 1965 ACTA MEDICA SCANDINAVICA 177(6):783-& JENSEN MK CHROMOSOME ABERRATIONS IN HUMAN CELLS INDUCED BY THALIDOMIDE IN VITRO - PRELIMINARY REPORT | 4 | 12 |
| 30 | 12 | 63 | 2566 2004 ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64(1):1-9 Greig NH; Giordano T; Zhu XX; Yu QS; Perry TA; Holloway HW; Brossi A; Rogers JT; Sambamurti K; Lahiri DK Thalidomide-based TNF-alpha inhibitors for neurodegenerative diseases | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 31 | 4 | 26 | 412 1967 ACTA NEUROLOGICA SCANDINAVICA S 43:5-& HAFSTROM T POLYNEUROPATHY AFTER NEUROSEDYN (THALIDOMIDE) AND ITS PROGNOSIS | 0 | 1 |
| 32 | 0 | 0 | 796 1983 ACTA NEUROLOGICA SCANDINAVICA 68(3):184-184 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 0 | 0 |
| 33 | 6 | 22 | 2567 2004 ACTA NEUROLOGICA SCANDINAVICA 109(3):188-193 Isoardo G; Bergui M; Durelli L; Barbero P; Boccadoro M; Bertola A; Ciaramitaro P; Palumbo A; Bergamasco B; Cocito D Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features | 0 | 0 |
| 34 | 2 | 28 | 635 1977 ACTA NEUROPATHOLOGICA 39(3):271-280 SCHRODER JM; GIBBELS E UNMYELINATED NERVE-FIBERS IN SENILE NERVES AND IN LATE THALIDOMIDE NEUROPATHY - QUANTITATIVE ELECTRON-MICROSCOPIC STUDY | 10 | 33 |
| 35 | 4 | 17 | 872 1985 ACTA NEUROPATHOLOGICA 65(3-4):285-292 SCHRODER JM; MATTHIESEN T EXPERIMENTAL THALIDOMIDE NEUROPATHY - THE MORPHOLOGICAL CORRELATE OF REDUCED CONDUCTION-VELOCITY | 5 | 7 |
| 36 | 9 | 18 | 1165 1995 ACTA NEUROPATHOLOGICA 89(5):415-419 SCHRODER JM; SELLHAUS B; WOHRMANN T; KOGEL B; ZWINGENBERGER K INHIBITORY EFFECTS OF THALIDOMIDE ON CELLULAR PROLIFERATION, ENDONEURIAL EDEMA AND MYELIN PHAGOCYTOSIS DURING EARLY WALLERIAN DEGENERATION | 6 | 9 |
| 37 | 3 | 6 | 2568 2004 ACTA ONCOLOGICA 43(2):215-216 Ribas C; Colleoni G; Almeida M; Duch CR; Ohashi C; Segreto R; Silva MR Response of plasmacytomas to low-dose thalidomide in a patient with refractory multiple myeloma | 0 | 0 |
| 38 | 1 | 6 | 359 1966 ACTA OPHTHALMOLOGICA 44(3):391-& ZETTERST.B OCULAR MALFORMATIONS CAUSED BY THALIDOMIDE | 0 | 18 |
| 39 | 11 | 33 | 1082 1993 ACTA OPHTHALMOLOGICA 71(2):238-245 STROMLAND K; MILLER MT THALIDOMIDE EMBRYOPATHY - REVISITED 27 YEARS LATER | 4 | 12 |
| 40 | 0 | 7 | 636 1977 ACTA ORTHOPAEDICA SCANDINAVICA 48(3):273-276 EDWARDS DH; NICHOLS PJR SPINAL ABNORMALITIES IN THALIDOMIDE EMBRYOPATHY | 4 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 41 | 0 | 0 | 180 1963 ACTA PAEDIATRICA 52(6):619-& PLUM P THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| 42 | 0 | 0 | 181 1963 ACTA PAEDIATRICA 52(6):627-& ROSENDAL T APLASIA AND HYPOPLASIA OF LABYRINTH FOLLOWING THALIDOMIDE | 0 | 0 |
| 43 | 0 | 0 | 306 1965 ACTA PAEDIATRICA SCANDINAVICA S:79-& DAVIGNON M; HELLGREN K; JUHLIN IM THALIDOMIDE DAMAGED CHILDREN EXPERIENCES FROM EUGENIAHEMMET | 0 | 0 |
| 44 | 0 | 0 | 540 1972 ACTA PAEDIATRICA SCANDINAVICA 61(4):497-& SCHAFER KH SPASTIC HYPERTROPHIC PYLORIC STENOSIS AS EMBRYONAL MALFORMATION CAUSED BY THALIDOMIDE | 1 | 3 |
| 45 | 1 | 9 | 637 1977 ACTA PAEDIATRICA SCANDINAVICA 66(6):673-675 BROOK CGD; JARVIS SN; NEWMAN CGH LINEAR GROWTH OF CHILDREN WITH LIMB DEFORMITIES FOLLOWING EXPOSURE TO THALIDOMIDE INUTERO | 3 | 3 |
| 46 | 1 | 5 | 182 1963 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA 58(3):355-& MIDTVEDT T EFFECT OF THALIDOMIDE ON GROWTH CURVE OF A RIBOFLAVIN DEPENDENT MICROBE | 0 | 5 |
| 47 | 23 | 44 | 183 1963 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA 59(4):491-& BACH A; BICHEL J; HEJGAARD JJ STUDIES ON POSSIBLE ANTI-NEOPLASTIC EFFECT OF THALIDOMIDE | 4 | 9 |
| 48 | 8 | 16 | 493 1970 ACTA PATHOLOGICA ET MICROBIOLOGICA SCANDINAVICA SECTION B- MICROBIOLOGY AND IMMUNOLOGY 78(4):488-& MIDTVEDT T; LINDSTED.G METABOLISM OF THALIDOMIDE IN PSEUDOMONAS-AERUGINOSA NCTC A7244 | 0 | 1 |
| 49 | 6 | 14 | 910 1986 ACTA PATHOLOGICA MICROBIOLOGICA ET IMMUNOLOGICA SCANDINAVICA SECTION C-IMMUNOLOGY 94(6):233-237 NIELSEN H; VALERIUS NH THALIDOMIDE ENHANCES SUPEROXIDE ANION RELEASE FROM HUMAN POLYMORPHONUCLEAR AND MONONUCLEAR LEUKOCYTES | 4 | 7 |
| 50 | 47 | 105 | 541 1972 ACTA PHARMACEUTICA SUECICA 9(6):521-542 JONSSON NA CHEMICAL STRUCTURE AND TERATOGENIC PROPERTIES .3. REVIEW OF AVAILABLE DATA ON STRUCTURE-ACTIVITY RELATIONSHIPS AND MECHANISM OF ACTION OF THALIDOMIDE ANALOGS | 17 | 26 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 51 | 11 | 51 | 542 1972 ACTA PHARMACEUTICA SUECICA 9(6):543-562 JONSSON NA CHEMICAL STRUCTURE AND TERATOGENIC PROPERTIES .4. OUTLINE OF A CHEMICAL HYPOTHESIS FOR TERATOGENIC ACTION OF THALIDOMIDE | 15 | 27 |
| 52 | 15 | 28 | 184 1963 ACTA PHARMACOLOGICA ET TOXICOLOGICA 20(3):186-& LARSEN V TERATOGENIC EFFECTS OF THALIDOMIDE, IMIPRAMINE HCL AND IMIPRAMINE-N-OXIDE HCL ON WHITE DANISH RABBITS | 5 | 20 |
| 53 | 1 | 11 | 360 1966 ACTA PHARMACOLOGICA ET TOXICOLOGICA 24(4):443-& LARSEN V; BREDAHL E EMBRYOTOXIC EFFECT ON RABBITS OF MONOPHENYLBUTAZONE (MONAZAN) COMPARED WITH PHENYLBUTAZONE AND THALIDOMIDE | 1 | 9 |
| 54 | 2 | 8 | 543 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):11-& JONSSON BG TERATOLOGICAL STUDIES ON THALIDOMIDE IN RATS | 0 | 1 |
| 55 | 2 | 5 | 544 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):17-& JONSSON BG TERATOLOGICAL STUDIES ON THALIDOMIDE IN RABBITS | 0 | 3 |
| 56 | 0 | 5 | 545 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):24-& JONSSON BG THALIDOMIDE TERATOLOGY IN SWINE - PREPARATORY STUDY | 0 | 0 |
| 57 | 2 | 13 | 546 1972 ACTA PHARMACOLOGICA ET TOXICOLOGICA 31(1-2):27-& JONSSON BG EFFECTS OF THALIDOMIDE ON EMBRYONIC-DEVELOPMENT OF AXOLOTL (AMBYSTOMA MEXICANUM) | 1 | 1 |
| 58 | 0 | 0 | 638 1977 ACTA PHYSIOLOGICA LATINOAMERICANA 27(6):377-378 MIRANDA RO; HASTINGS RC THALIDOMIDE INHIBITION OF ANTIBODY-SYNTHESIS | 0 | 0 |
| 59 | 0 | 1 | 185 1963 ACTA PHYSIOLOGICA SCANDINAVICA 59:21-& BERGSTROM RM; PUTKONEN P; BERGSTROM L EFFECT OF THALIDOMIDE ON ELECTROENCEPHALOGRAM (EEG) OF INTRAUTERINE GUINEA PIG FOETUS | 0 | 1 |
| 60 | 0 | 0 | 186 1963 ACTA PHYSIOLOGICA SCANDINAVICA 59:87-& LARSEN V TERATOGENIC EFFECTS OF THALIDOMIDE, IMIPRAMINE HCL AND IMIPRAMINE N-OXIDE HCL ON WHITE DANISH RABBITS | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 61 | 2 | 5 | 307 1965 ACTA RADIOLOGICA-DIAGNOSIS 3(2):145-& GATZEK H; DIPAOLO JA RADIOGRAPHIC STUDIES OF THALIDOMIDE-INDUCED MALFORMATIONS IN MICE | 0 | 2 |
| 62 | 10 | 44 | 308 1965 ACTA RADIOLOGICA-DIAGNOSIS 3(3):225-& ROSENDAL T APLASIA-HYPOPLASIA OF OTIC LABYRINTH AFTER THALIDOMIDE | 0 | 9 |
| 63 | 36 | 79 | 413 1967 ACTA VITAMINOLOGICA ET ENZYMOLOGICA 21(4):123-& FABRO S ON MECHANISM OF TERATOGENIC ACTION OF THALIDOMIDE | 1 | 1 |
| 64 | 8 | 11 | 2296 2003 ADAMANTIADES-BEHCET'S DISEASE 528:585-589 Sohn S; Lee ES; Lee SI; Kim YA; Kwon HJ; Bang D; Lei S Therapeutic effect of thalidomide through cytokine and chemokine regulation in herpes simplex virus-induced Behcet's disease-like animal model | 0 | 0 |
| 65 | 37 | 61 | 1114 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(2):65-76 DARCY PF; GRIFFIN JP THALIDOMIDE REVISITED | 21 | 26 |
| 66 | 32 | 85 | 1115 1994 ADVERSE DRUG REACTIONS AND TOXICOLOGICAL REVIEWS 13(4):177-192 CRAWFORD CL USE OF THALIDOMIDE IN LEPROSY | 8 | 11 |
| 67 | 0 | 8 | 414 1967 AGRI HORTIQUE GENETICA 25(3-4):99-& BLIXT S STUDIES OF INDUCED MUTATION IN PEAS .19. TREATMENT WITH HYDROXYLAMINE FLUORODEOXYURIDIN DEOXYURIDIN AND THALIDOMIDE | 0 | 2 |
| 68 | 1 | 5 | 1166 1995 AIDS 9(6):658-659 SHARPSTONE D; ROWBOTTOM A; NELSON M; GAZZARD B THE TREATMENT OF MICROSPORIDIAL DIARRHEA WITH THALIDOMIDE | 14 | 34 |
| 69 | 0 | 0 | 1224 1996 AIDS 10:P60-P60 FeregrinoGoyos M; GomezCaro WH; AlvaradoDiez R; Yieyra MPM; TorrasGiner V Thalidomide and ketoprofen reduce the incidence of adverse events of interleukin 2 and enhance the antiviral activity of CD8 in HIV/AIDS patients. | 0 | 0 |
| 70 | 0 | 0 | 1225 1996 AIDS 10:P102-P102 MacRedmond R; Keating S; Armstrong S; Ryan M; Mulcahy FM The use of oral thalidomide in the treatment of oesophageal ulceration in AIDS. | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 71 | 6 | 38 | 1226 1996 AIDS 10(13):1501-1507 ReyesTeran G; SierraMadero JG; delCerro VM; ArroyoFigueroa H; Pasquetti A; Calva JJ; RuizPalacios GM Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double-blind, placebo-controlled clinical trial | 49 | 97 |
| 72 | 2 | 8 | 1392 1998 AIDS 12(3):334-335 Di Fabio S; Trabattoni D; Geraci A; Ruzzante S; Panzini G; Fusi ML; Chiarotti F; Corrias F; Belli R; Verani P; Dalgleish A; Clerici M Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys | 0 | 0 |
| 73 | 5 | 5 | 1608 2000 AIDS 14(12):1859-1861 Gori A; Rossi MC; Marchetti G; Trabattoni D; Molteni C; Cogliati M; Bandera A; Clerici M; Franzetti F Clinical and immunological benefit of adjuvant therapy with thalidomide in the treatment of tuberculosis disease | 5 | 7 |
| 74 | 7 | 11 | 2017 2002 AIDS 16(17):2355-2356 Teo S; Noormohamed F; Youle M; Johnson M; Peters B; Stirling D; Thomas S Transient increase in plasma HIV-1 viral load and associated weight gain after thalidomide dosing | 1 | 1 |
| 75 | 0 | 0 | 1227 1996 AIDS PATIENT CARE AND STDS 10(1):51-51 [Anon] Thalidomide effective in treating AIDS-related mouth ulcers | 0 | 0 |
| 76 | 0 | 0 | 1228 1996 AIDS PATIENT CARE AND STDS 10(4):263-263 [Anon] Thalidomide trial for diarrhea | 0 | 0 |
| 77 | 0 | 0 | 1299 1997 AIDS PATIENT CARE AND STDS 11(4):292-292 [Anon] Limited course of thalidomide effective in treating AIDS-related mouth ulcers | 0 | 0 |
| 78 | 0 | 0 | 1300 1997 AIDS PATIENT CARE AND STDS 11(4):292-293 [Anon] Clinical sites initiated for thalidomide aphthous ulcer study | 0 | 0 |
| 79 | 0 | 0 | 1301 1997 AIDS PATIENT CARE AND STDS 11(4):296-296 [Anon] Positive results reported for thalidomide in AIDS wasting | 0 | 0 |
| 80 | 0 | 0 | 1393 1998 AIDS PATIENT CARE AND STDS 12(3):231-231 [Anon] Thalidomide studied in asymptomatic patients | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 81 | 7 | 10 | 1394 1998 AIDS PATIENT CARE AND STDS 12(12):903-906 Fu CS; Conteas CN; LaRiviere MJ Successful treatment of idiopathic colitis and proctitis using thalidomide in persons infected with human immunodeficiency virus | 2 | 3 |
| 82 | 8 | 16 | 1302 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(4):301-304 Alexander LN; Wilcox CM A prospective trial of thalidomide for the treatment of HIV-associated idiopathic esophageal ulcers | 25 | 32 |
| 83 | 12 | 43 | 1303 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(10):857-863 Moreira AL; Corral LG; Ye WG; Johnson B; Stirling D; Muller GW; Freedman VH; Kaplan G Thalidomide and thalidomide analogs reduce HIV type 1 replication in human macrophages in vitro | 36 | 47 |
| 84 | 7 | 25 | 1304 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(12):1047-1054 Haslett P; Hempstead M; Seidman C; Diakun J; Vasquez D; Freedman VH; Kaplan G The metabolic and immunologic effects of short-term thalidomide treatment of patients infected with the human immunodeficiency virus | 36 | 57 |
| 85 | 7 | 20 | 1305 1997 AIDS RESEARCH AND HUMAN RETROVIRUSES 13(18):1625-1631 Marriott JB; Cookson S; Carlin E; Youle M; Hawkins DA; Nelson M; Pearson P; Vaughan AN; Gazzard B; Dalgleish AG A double-blind placebo-controlled phase II trial of thalidomide in asymptomatic HIV-positive patients: Clinical tolerance and effect on activation markers and cytokines | 9 | 14 |
| 86 | 25 | 30 | 1481 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(12):1047-1052 Noormohamed FH; Youle MS; Higgs CJ; Kook KA; Hawkins DA; Lant AF; Thomas SD Pharmacokinetics and hemodynamic effects of single oral doses of thalidomide in asymptomatic human immunodeficiency virus-infected subjects | 13 | 13 |
| 87 | 12 | 39 | 1482 1999 AIDS RESEARCH AND HUMAN RETROVIRUSES 15(13):1169-1179 Haslett PAJ; Klausner JD; Makonkawkeyoon S; Moreira A; Metatratip P; Boyle B; Kunachiwa W; Maneekarn N; Vongchan P; Corral LG; Elbeik T; Shen Z; Kaplan G Thalidomide stimulates T cell responses and interleukin 12 production in HIV-infected patients | 27 | 33 |
| 88 | 17 | 32 | 1609 2000 AIDS RESEARCH AND HUMAN RETROVIRUSES 16(14):1345-1355 Kaplan G; Thomas S; Fierer DS; Mulligan K; Haslett PAJ; Fessel WJ; Smith LG; Kook KA; Stirling D; Schambelan M Thalidomide for the treatment of AIDS-associated wasting | 13 | 27 |
| 89 | 17 | 24 | 2018 2002 AKTUELLE NEUROLOGIE 29(3):149-152 Vogt T; Nill M; Hundsberger T Thalidomide neuropathy | 0 | 0 |
| 90 | 8 | 31 | 2297 2003 ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH 27(8):2S-6S Enomoto N; Takei Y; Hirose M; Kitamura T; Ikejima K; Sato N Protective effect of thalidomide on endotoxin-induced liver injury | 0 | 1 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 91 | 21 | 36 | 2019 2002 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 16(6):1117-1124 Sabate JM; Villarejo J; Lemann M; Bonnet J; Allez M; Modigliani R An open-label study of thalidomide for maintenance therapy in responders to infliximab in chronically active and fistulizing refractory Crohn's disease | 4 | 14 |
| 92 | 8 | 26 | 2020 2002 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 16(12):2115-2122 Ginsburg PM; Ehrenpreis ED A pilot study of thalidomide for patients with symptomatic mesenteric panniculitis | 0 | 1 |
| 93 | 11 | 28 | 2298 2003 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 17(5):677-682 Khan ZH; Simpson EJ; Cole AT; Holt M; MacDonald I; Pye D; Austin A; Freeman JG Oesophageal cancer and cachexia: the effect of short-term treatment with thalidomide on weight loss and lean body mass | 0 | 1 |
| 94 | 10 | 60 | 2569 2004 ALIMENTARY PHARMACOLOGY & THERAPEUTICS 19(1):79-88 Austin AS; Mahida YR; Clarke D; Ryder SD; Freeman JG A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis | 0 | 0 |
| 95 | 0 | 16 | 2021 2002 AMERICAN BIOLOGY TEACHER 64(7):495-500 Seidman LA; Warren NN Frances Kelsey & thalidomide in the US: A case study relating to pharmaceutical regulations | 0 | 0 |
| 96 | 9 | 12 | 264 1964 AMERICAN HEART JOURNAL 67(2):184-& MARTIN JK CONGENITAL MALFORMATIONS ASSOCIATED WITH THALIDOMIDE + THEIR MANAGEMENT | 0 | 0 |
| 97 | 13 | 27 | 2022 2002 AMERICAN HEART JOURNAL 144(5):847-850 Gullestad L; Semb AG; Holt E; Skardal R; Ueland T; Yndestad A; Froland SS; Aukrust P Effect of thalidomide in patients with chronic heart failure | 1 | 4 |
| 98 | 15 | 16 | 2570 2004 AMERICAN JOURNAL OF CARDIOLOGY 93(8):1052-1055 Fahdi IE; Gaddam V; Saucedo JF; Kishan CV; Vyas K; Deneke MG; Razek H; Thorn B; Bissett JK; Anaisse E; Barlogie B; Mehta JL Bradycardia during therapy for multiple myeloma with thalidomide | 0 | 0 |
| 99 | 56 | 65 | 2299 2003 AMERICAN JOURNAL OF CLINICAL DERMATOLOGY 4(6):379-387 Pelle MT; Werth VP Thalidomide in cutaneous lupus erythematosus | 0 | 0 |
| 100 | 3 | 14 | 1610 2000 AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 23(3):319-321 Patt YZ; Hassan MM; Lozano RD; Ellis LM; Peterson JA; Waugh KA Durable clinical response of refractory hepatocellular carcinoma to orally administered thalidomide | 14 | 25 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 101 | 0 | 0 | 50 1962 AMERICAN JOURNAL OF DISEASES OF CHILDREN 104(2):111-& TAUSSIG HB THALIDOMIDE-A LESSON IN REMOTE EFFECTS OF DRUGS | 0 | 5 |
| 102 | 0 | 0 | 1229 1996 AMERICAN JOURNAL OF EPIDEMIOLOGY 143(11):6-6 Yang Q; Khoury MJ; James LM; Olney RS; Paulozzi LJ The return of thalidomide? Are birth defects surveillance systems ready? | 0 | 1 |
| 103 | 10 | 11 | 1306 1997 AMERICAN JOURNAL OF GASTROENTEROLOGY 92(1):169-170 Ball SC; Sepkowitz KA; Jacobs JL Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: Case report and review | 12 | 13 |
| 104 | 4 | 7 | 1801 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(4):1305-1306 Ginsburg PM; Hanan I; Ehrenpreis ED Treatment of severe esophageal Crohn's disease with thalidomide | 8 | 10 |
| 105 | 8 | 12 | 1802 2001 AMERICAN JOURNAL OF GASTROENTEROLOGY 96(11):3207-3209 Raufman JP; Lamps LW Thalidomide-induced normalization of serum ALT levels in a patient with hepatitis C | 0 | 0 |
| 106 | 1 | 6 | 2300 2003 AMERICAN JOURNAL OF GASTROENTEROLOGY 98(1):221-222 Shurafa M; Kamboj G Thalidomide for the treatment of bleeding angiodysplasias | 1 | 2 |
| 107 | 9 | 12 | 1230 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):368-& Weidle PJ Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus | 5 | 5 |
| 108 | 11 | 16 | 1231 1996 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 53(4):429-431 Minor JR; Piscitelli SC Thalidomide in diseases associated with human immunodeficiency virus infection | 3 | 4 |
| 109 | 0 | 1 | 1307 1997 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 54(13):1485-1486 [Anon] Thalidomide heals HIV-related oral ulcers, but caution is required | 0 | 0 |
| 110 | 0 | 0 | 1308 1997 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 54(20):2270-& Miller JL Thalidomide recommended for approval under tight restrictions | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 111 | 0 | 0 | 1395 1998 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 55(17):1746-+ Kepple SR Thalidomide approval brings tight restrictions on access | 1 | 1 |
| 112 | 1 | 1 | 1483 1999 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 56(17):1721-1725 Keravich DP; Daniels CE Challenges of thalidomide distribution in a hospital setting | 0 | 0 |
| 113 | 7 | 12 | 1611 2000 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 57(17):1607-1610 Eriksson T; Wallin R; Hoglund P; Roth B; Qi ZQ; Ostraat O; Bjorkman S Low bioavailability of rectally administered thalidomide | 2 | 2 |
| 114 | 0 | 0 | 2023 2002 AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY 59(18):1700-+ Young D Thalidomide prescribers cannot assign survey responsibility to pharmacists | 0 | 0 |
| 115 | 8 | 12 | 1803 2001 AMERICAN JOURNAL OF HEMATOLOGY 66(4):300-302 Fowler R; Imrie K Thalidomide-associated hepatitis: A case report | 5 | 6 |
| 116 | 3 | 3 | 2024 2002 AMERICAN JOURNAL OF HEMATOLOGY 70(3):265-265 Pulik M; Genet P; Lionnet F; Touahri T Thalidomide-associated gynecomasty in a patient with multiple myeloma | 1 | 1 |
| 117 | 4 | 37 | 2301 2003 AMERICAN JOURNAL OF HEMATOLOGY 73(1):48-53 Lee FC; Merchant SH Alleviation of systemic manifestations of multicentric Castleman's disease by thalidomide | 1 | 2 |
| 118 | 3 | 10 | 2302 2003 AMERICAN JOURNAL OF HEMATOLOGY 74(3):205-207 Barton JC Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia | 0 | 0 |
| 119 | 1 | 5 | 2303 2003 AMERICAN JOURNAL OF HEMATOLOGY 74(4):290-291 Gomez-Rangel JD; Ruiz-Delgadoz GJ; Ruiz-Arguelles GJ Pegylated-interferon induced severe bone marrow hypoplasia in a patient with multiple myelorna receiving thalidomide | 0 | 0 |
| 120 | 2 | 5 | 2571 2004 AMERICAN JOURNAL OF HEMATOLOGY 75(3):176-177 Jung CP; Emmerich B; Goebel FD; Bogner JR Successful treatment of a patient with HIV-associated multicentric castleman disease (MCD) with thalidomide | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 121 | 3 | 15 | 2572 2004 AMERICAN JOURNAL OF HEMATOLOGY 76(1):66-68 Sinisalo M; Hietaharju A; Sauranen J; Wirta O Thalidomide in POEMS syndrome: Case report | 0 | 0 |
| 122 | 0 | 0 | 1612 2000 AMERICAN JOURNAL OF HUMAN GENETICS 67(4):134-134 Nippert I 40 years later: The health related quality of life of women affected by Thalidomide. | 0 | 0 |
| 123 | 0 | 0 | 2304 2003 AMERICAN JOURNAL OF HUMAN GENETICS 73(5):197-197 Kohlhase J; Schubert L; Liebers M; Hennekam RCM; Rauch A; Becker K; Mohammed SN; Wright M; Hannibal MC; Newbury-Ecob R; Reardon W SALL4 mutations result in a range of clinically overlapping phenotypes, including Okihiro syndrome, Holt-Oram syndrome, Acro-Reno-Ocular syndrome and patients previously reported to represent Thalidomide Embryopathy. | 0 | 0 |
| 124 | 0 | 0 | 2305 2003 AMERICAN JOURNAL OF HUMAN GENETICS 73(5):286-286 Pan P; Omlin K; Rosenthal J; Padilla O; Stadecker M; Demmer L A case of Restrictive Dermopathy with survival beyond the neonatal period and novel experience with thalidomide therapy | 0 | 0 |
| 125 | 3 | 44 | 1309 1997 AMERICAN JOURNAL OF MEDICAL GENETICS 73(3):251-258 Yang QH; Khoury MJ; James LM; Olney RS; Paulozzi LJ; Erickson JD The return of thalidomide: Are birth defects surveillance systems ready? | 1 | 6 |
| 126 | 71 | 96 | 1613 2000 AMERICAN JOURNAL OF MEDICINE 108(6):487-495 Calabrese L; Fleischer AB Thalidomide: Current and potential clinical applications | 58 | 99 |
| 127 | 6 | 16 | 2025 2002 AMERICAN JOURNAL OF MEDICINE 112(5):412-413 Badros AZ; Siegel E; Bodenner D; Zangari M; Zeldis J; Barlogie B; Tricot G Hypothyroidism in patients with multiple myeloma following treatment with thalidomide | 8 | 9 |
| 128 | 12 | 27 | 2026 2002 AMERICAN JOURNAL OF MEDICINE 113(7):603-606 Bennett CL; Schumock GT; Desai AA; Kwaan HC; Raisch DW; Newlin R; Stadler W Thalidomide-associated deep vein thrombosis and pulmonary embolism | 3 | 6 |
| 129 | 1 | 10 | 2306 2003 AMERICAN JOURNAL OF MEDICINE 115(4):332-334 Staak JO; Glossmann JP; Esser JM; Diehl V; Mietz H; Josting A Thalidomide for systemic capillary leak syndrome | 0 | 0 |
| 130 | 11 | 60 | 1614 2000 AMERICAN JOURNAL OF NEURORADIOLOGY 21(5):881-890 Cha S; Knopp EA; Johnson G; Litt A; Glass J; Gruber ML; Lu S; Zagzag D Dynamic contrast-enhanced T2*-weighted MR imaging of recurrent malignant gliomas treated with thalidomide and carboplatin | 2 | 23 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 131 | 5 | 11 | 361 1966 AMERICAN JOURNAL OF NURSING 66(9):2023-2026 SOULES BJ THALIDOMIDE VICTIMS IN A REHABILITATION CENTER | 0 | 0 |
| 132 | 2 | 13 | 11 1961 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 81(6):1245-& NULSEN RO TRIAL OF THALIDOMIDE IN INSOMNIA ASSOCIATED WITH THIRD TRIMESTER | 1 | 1 |
| 133 | 0 | 0 | 51 1962 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 84(7):979-& TAUSSIG HB PHOCOMELIA AND THALIDOMIDE | 0 | 0 |
| 134 | 15 | 52 | 309 1965 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 91(2):260-& MCCAFFER.RE; WOOD ML; KNISELY WH MORPHOLOGICAL AND PHYSIOLOGICAL EFFECTS OF THALIDOMIDE AND TRYPAN BLUE ON UTERI AND CONCEPTI OF GRAVID MICE | 0 | 2 |
| 135 | 1 | 2 | 445 1968 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 100(4):536-& SAMOJLIK E; LESINSKI J INFLUENCE OF THALIDOMIDE ON FERTILITY AND ON REPRODUCTIVE ORGANS IN RATS - PRELIMINARY COMMUNICATION | 0 | 0 |
| 136 | 10 | 17 | 446 1968 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 100(7):952-& GUSDON JP; COHEN C EFFECT OF THALIDOMIDE ON ANTIBODY RESPONSE | 21 | 22 |
| 137 | 5 | 7 | 447 1968 AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 102(8):1179-& BLAKE DA; FLEISCHE.CA; WYNN RL; GUSDON JP; COHEN C THALIDOMIDE SOLUTION | 0 | 0 |
| 138 | 0 | 1 | 547 1972 AMERICAN JOURNAL OF OCCUPATIONAL THERAPY 26(8):440-440 POSTHUMA BW ABNORMALITY AND NORMALITY - MOTHERING OF THALIDOMIDE CHILDREN - ROSKIES,E | 0 | 0 |
| 139 | 0 | 0 | 362 1966 AMERICAN JOURNAL OF OPHTHALMOLOGY 62(5):982-& RAFUSE E; ARSTIKAI.MJ EYE FINDINGS IN 20-THALIDOMIDE BABIES | 0 | 0 |
| 140 | 2 | 4 | 1232 1996 AMERICAN JOURNAL OF OPHTHALMOLOGY 122(4):594-595 Ip M; Gorin MB Recurrence of a choroidal neovascular membrane in a patient with punctate inner choroidopathy treated with daily doses of thalidomide | 4 | 13 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 141 | 4 | 25 | 187 1963 AMERICAN JOURNAL OF PATHOLOGY 43(6):999-& MARINPADILLA M; BENIRSCHKE K THALIDOMIDE INDUCED ALTERATIONS IN BLASTOCYST AND PLACENTA OF ARMADILLO, DASYPUS NOVEMCINCTUS MEXICANUS, INCLUDING A CHORIOCARCINOMA | 6 | 35 |
| 142 | 9 | 24 | 1615 2000 AMERICAN JOURNAL OF PATHOLOGY 156(1):151-158 Sauer H; Gunther J; Hescheler J; Wartenberg M Thalidomide inhibits angiogenesis in embryoid bodies by the generation of hydroxyl radicals | 16 | 33 |
| 143 | 0 | 0 | 474 1969 AMERICAN JOURNAL OF PHYSICAL ANTHROPOLOGY 31(2):267-& LINDBURG DG BEHAVIOR OF MONKEYS WITH THALIDOMIDE-INDUCED MALFORMATIONS | 0 | 0 |
| 144 | 0 | 0 | 797 1983 AMERICAN JOURNAL OF PRIMATOLOGY 4(4):336-336 NEWMAN L; HENDRICKX A FETAL DEVELOPMENT IN THE NORMAL AND THALIDOMIDE-EXPOSED THICK-TAILED BUSHBABY | 0 | 0 |
| 145 | 0 | 0 | 873 1985 AMERICAN JOURNAL OF PRIMATOLOGY 8(4):355-355 NEWMAN L; HENDERICKX A INTERSPECIES VARIATION IN FETAL OTOTEMPOROMANDIBULAR ANOMALIES FOLLOWING MATERNAL THALIDOMIDE EXPOSURE | 0 | 0 |
| 146 | 1 | 2 | 5 1960 AMERICAN JOURNAL OF PSYCHIATRY 116(11):1030-1031 COHEN S SLEEP REGULATION WITH THALIDOMIDE | 4 | 9 |
| 147 | 0 | 10 | 12 1961 AMERICAN JOURNAL OF PSYCHIATRY 118(6):554-& AZIMA H; ARTHURS D CONTROL STUDY OF THALIDOMIDE (KEVADON), A NEW HYPNOTIC AGENT | 0 | 2 |
| 148 | 8 | 24 | 1484 1999 AMERICAN JOURNAL OF PUBLIC HEALTH 89(1):98-101 Annas GJ; Elias S Thalidomide and the Titanic: Reconstructing the technology tragedies of the twentieth century | 5 | 7 |
| 149 | 0 | 0 | 310 1965 AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH 55(5):703-707 KELSEY FO PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961 | 1 | 3 |
| 150 | 0 | 0 | 1485 1999 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 159(3):A271-A271 Lindsay L; Oliver S; Freeman S; Regis J; Krauss A; Kaplan G The role of thalidomide and steroid in modulating the expression of TNF-alpha (TNA-a) and IL-6 in the hyperoxic newborn rat lung. | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 151 | 35 | 44 | 1804 2001 AMERICAN JOURNAL OF THE MEDICAL SCIENCES 321(5):321-326 Moraes M; Russo G Thalidomide and its dermatologic uses | 3 | 9 |
| 152 | 11 | 27 | 415 1967 AMERICAN JOURNAL OF VETERINARY RESEARCH 28(127):1823-& SZABO KT; STEELMAN RL EFFECTS OF MATERNAL THALIDOMIDE TREATMENT ON PREGNANCY FETAL DEVELOPMENT AND MORTALITY OF OFFSPRING IN RANDOM-BRED MICE | 12 | 12 |
| 153 | 3 | 27 | 416 1967 AMERICAN JOURNAL OF VETERINARY RESEARCH 28(127):1829-& SZABO KT; STEELMAN RL EFFECTS OF THALIDOMIDE TREATMENT OF INBRED FEMALE MICE ON PREGNANCY FETAL DEVELOPMENT AND MORTALITY OF OFFSPRING | 2 | 2 |
| 154 | 18 | 33 | 2573 2004 AMERICAN JOURNAL OF VETERINARY RESEARCH 65(5):659-664 Farese JR; Fox LE; Detrisac CJ; Van Gilder JA; Roberts SL; Baldwin JA Effect of thalidomide on growth and metastasis of canine osteosarcoma cells after xenotransplantation in athymic mice | 0 | 0 |
| 155 | 0 | 1 | 1083 1993 AMERICAN SCIENTIST 81(5):425-426 HOFFMAN M A 2ND CHANCE FOR THALIDOMIDE | 0 | 0 |
| 156 | 0 | 0 | 52 1962 AMERICAN ZOOLOGIST 2(4):559-559 SMITH TE; BERNDT WO; OLEARY JF; CAVANAUGH DJ THE INVITRO INHIBITORY EFFECT OF THALIDOMIDE ON THE CHICK EMBRYO | 0 | 0 |
| 157 | 8 | 13 | 2307 2003 AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS 10(4):257-261 Dispenzieri A; Lacy MQ; Rajkumar SV; Geyer SM; Witzig TE; Fonseca R; Lust JA; Greipp PR; Kyle RA; Gertz MA Poor tolerance to high doses of thalidomide in patients with primary systemic amyloidosis | 0 | 0 |
| 158 | 0 | 5 | 954 1988 ANAESTHESIA 43(7):613-614 MCCRORY JW ANESTHESIA AND THALIDOMIDE-RELATED ABNORMALITIES | 1 | 1 |
| 159 | 1 | 1 | 986 1989 ANAESTHESIA 44(1):69-69 GRAYLING GW; YOUNG PN ANESTHESIA AND THALIDOMIDE-RELATED ABNORMALITIES | 0 | 0 |
| 160 | 0 | 1 | 265 1964 ANALYTICA CHIMICA ACTA 30(3):313-& HETMAN JS POLAROGRAPHIC DETERMINATION OF N-PHTHALYLGLUTAMIC ACID IMIDE ( THALIDOMIDE ) | 2 | 6 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 161 | 10 | 12 | 1310 1997 ANALYTICA CHIMICA ACTA 339(1-2):91-97 Simmons BR; Lush RM; Figg WD A reversed-phase high performance liquid chromatography method using solid phase extraction to quantitate thalidomide in human serum | 8 | 10 |
| 162 | 3 | 8 | 266 1964 ANALYTICAL BIOCHEMISTRY 8(1):129-& SANDBERG DH; TURNER DA; BOCK SA QUANTITATIVE MEASUREMENT OF THALIDOMIDE BY GAS-LIQUID CHROMATOGRAPHY | 2 | 4 |
| 163 | 15 | 40 | 2027 2002 ANALYTICAL CHEMISTRY 74(15):3726-3735 Meyring M; Muhlbacher J; Messer K; Kastner-Pustet N; Bringmann G; Mannschreck A; Blaschke G In vitro biotransformation of (R)- and (S)-thalidomide: Application of circular dichroism spectroscopy to the stereochemical characterization of the hydroxylated metabolites | 0 | 2 |
| 164 | 0 | 0 | 267 1964 ANATOMICAL RECORD 148(2):313-& MOORE KL; DWORNIK JJ; DALTON RD CONGENITAL DEFECTS PRODUCED IN RAT BY THALIDOMIDE | 2 | 5 |
| 165 | 0 | 0 | 268 1964 ANATOMICAL RECORD 148(2):375-& HAGEN EO CONGENITAL ANOMALIES OF LIMBS ASSOCIATED WITH MATERNAL INGESTION OF THALIDOMIDE | 0 | 0 |
| 166 | 7 | 18 | 269 1964 ANATOMICAL RECORD 149(1):149-& DIPAOLO JA; PICKREN J; GATZEK H MALFORMATIONS INDUCED IN MOUSE BY THALIDOMIDE | 9 | 18 |
| 167 | 2 | 7 | 270 1964 ANATOMICAL RECORD 149(3):359-& MARINPADILLA M THALIDOMIDE INJURY TO IMPLANTED ARMADILLO BLASTOCYST | 3 | 6 |
| 168 | 0 | 0 | 417 1967 ANATOMICAL RECORD 157(2):342-& WILSON JG; GAVAN JA THALIDOMIDE SYNDROME OF MALFORMATIONS PRODUCED IN RHESUS MONKEYS | 0 | 7 |
| 169 | 0 | 0 | 475 1969 ANATOMICAL RECORD 163(2):189-& GILANI SH EFFECTS OF THALIDOMIDE ON CARDIOVASCULAR DEVELOPMENT OF CHICK EMBRYO | 0 | 0 |
| 170 | 0 | 0 | 476 1969 ANATOMICAL RECORD 163(2):230-& MITCHELL JT STUDIES WITH THALIDOMIDE AND RELATED COMPOUNDS ON EARLY DEVELOPING MOUSE EMBRYOS | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 171 | 0 | 0 | 494 1970 ANATOMICAL RECORD 166(2):306-& GIACONE J; SCHMIDT HL INTERNAL MALFORMATIONS PRODUCED BY THALIDOMIDE AND RELATED COMPOUNDS IN RHESUS MONKEYS | 1 | 2 |
| 172 | 0 | 0 | 495 1970 ANATOMICAL RECORD 166(2):349-& MITCHELL JT THALIDOMIDE-INDUCED MALFORMATIONS IN EMBRYO OF COMMON SNAPPING TURTLE, CHELYDRA SERPENTINA | 0 | 0 |
| 173 | 0 | 0 | 513 1971 ANATOMICAL RECORD 169(2):274-& BATTINIC.WR EFFECTS OF THALIDOMIDE ON EARLY LIMB DEVELOPMENT IN RHESUS MONKEY (MACACA-MULATTA) | 0 | 1 |
| 174 | 0 | 0 | 609 1975 ANATOMICAL RECORD 181(2):428-429 MITCHELL JT COMPARATIVE TERATOGENIC EFFECTS OF MALATHION, CAPTAN, AND THALIDOMIDE IN EMBRYO OF COMMON SNAPPING TURTLE, CHELYDRA-SERPENTINA | 0 | 1 |
| 175 | 0 | 0 | 639 1977 ANATOMICAL RECORD 187(4):667-668 NEWMAN LM STRUCTURAL EAR MALFORMATIONS INDUCED BY THALIDOMIDE IN FETAL BONNET MONKEY (M-RADIATA) | 0 | 0 |
| 176 | 10 | 28 | 548 1972 ANNALEN DER CHEMIE-JUSTUS LIEBIG 755(NJAN):51-& KOCH H; KOTLAN J; FARKOUH E; PISCHEK G THALIDOMIDE ANALOGS .4. | 1 | 2 |
| 177 | 22 | 55 | 717 1980 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 107(6):515-523 SAMSOEN M; GROSSHANS E; BASSET A THALIDOMIDE IN THE TREATMENT OF DISCOID LUPUS-ERYTHEMATOSUS (DLE) | 47 | 55 |
| 178 | 3 | 4 | 798 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(6-7):551-552 NOUGUE J; NOUGUE M; BAZEX J; HAYEK JP; BIDOUZE H OCCURRENCE OF A GENITAL HEMORRHAGIC DURING A THALIDOMIDE TREATED PRURIGO NODULARIS | 3 | 3 |
| 179 | 3 | 17 | 799 1983 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 110(8):611-614 MOULIN G; BONNET F; BARRUT D; FRANC MP TREATMENT OF JESSNER-KANOF DISEASE WITH THALIDOMIDE | 12 | 21 |
| 180 | 0 | 0 | 840 1984 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 111(3):285-286 SCHNITZLER L THALIDOMIDE IN HAILEY-HAILEY DISEASE - GOOD BUT PALLIATIVE RESULTS | 4 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 181 | 0 | 0 | 841 1984 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 111(3):289-290 VIGNOLLY B; GENIAUX M; ROMMEL A; TEXIER L BEHCET DISEASE, NODOUS ERYTHEMA AND THALIDOMIDE | 0 | 0 |
| 182 | 0 | 0 | 874 1985 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 112(1):90-90 DELSOL G; DUPRE A; VIRABEN R ROSAI-DORFMAN HISTIOCYTOSIS IN A PURE CUTANEOUS FORM - THE THERAPEUTIC USE OF THALIDOMIDE | 0 | 0 |
| 183 | 0 | 0 | 911 1986 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 113(5):499-499 REVUZ J; COTTENOT F; ORTONNE JP; GUILLAUME JC THALIDOMIDE ON TRIAL | 0 | 0 |
| 184 | 0 | 0 | 938 1987 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 114(9):1176-1176 CAMBAZARD F; LAFFAY A; VEDRINNE JM; THIVOLET J NEUROLOGICAL COMPLICATIONS OF THALIDOMIDE - STUDY OF 55 DERMATOLOGY PATIENTS (WITH THE EXCEPTION OF HANSENS-DISEASE PATIENTS) | 0 | 0 |
| 185 | 0 | 4 | 939 1987 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 114(11):1387-1389 GNASSIA AM; GNASSIA RT; BONVALET D; PUISSANT A; GOUDAL H HISTIOCYTOSIS-X WITH VULVAR LOCALIZATION - DRAMATIC EFFECT OF THALIDOMIDE | 15 | 23 |
| 186 | 63 | 106 | 1003 1990 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 117(4):313-321 REVUZ J THALIDOMIDE | 16 | 21 |
| 187 | 1 | 6 | 1052 1992 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 119(4):281-283 BENSAID P; MACHET L; VAILLANT L; MACHET MC; SCOTTO B; LORETTE G ADULT LANGERHANS-CELL HISTIOCYTOSIS - REGRESSION OF PAROTID-GLAND INVOLVEMENT AFTER THALIDOMIDE TREATMENT | 13 | 18 |
| 188 | 0 | 8 | 1167 1995 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 122(9):609-611 Safa G; Joly P; Boullie MC; Thomine E; Lauret P Treatment of 2 cases of Melkersson-Rosenthal syndrome with thalidomide | 3 | 8 |
| 189 | 3 | 13 | 1233 1996 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 123(6-7):375-377 Cherouati K; Claudy A; Souteyrand P; Cambazard F; Vaillant L; Moulin G; Crickx B; Morel P; Lamorelle A; Revuz J Thalidomide treatment of chronic erythema multiforme recurrent and continuous variants. A retrospective study of 26 patients. | 6 | 7 |
| 190 | 10 | 20 | 1616 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(2):171-174 Flageul B; Wallach D; Cavelier-Balloy B; Bachelez H; Carsuzaa F; Dubertret L Thalidomide and thrombosis. | 25 | 27 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 191 | 91 | 116 | 1617 2000 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 127(6-7):603-613 Laffitte E; Revuz J Thalidomide | 7 | 8 |
| 192 | 1 | 1 | 1805 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(1):87-87 Schmutz JL; Barbaud A; Trechot P Buccal lichen after thalidomide | 0 | 0 |
| 193 | 3 | 7 | 1806 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(2):148-149 Esteve E; Legac E Deep vein thrombosis and pulmonary embolism in a patient with aphtosis treated with thalidomide | 4 | 4 |
| 194 | 11 | 12 | 1807 2001 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 128(5):611-613 Estines O; Revuz J; Wolkenstein P; Bressieux JM; Roujeau JC; Cosnes A Sarcoidosis: thalidomide treatment in ten patients | 5 | 6 |
| 195 | 6 | 6 | 2308 2003 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 130(4):489-489 Schmutz JL; Barbaud A; Trechot P Thalidomide and thrombosis | 0 | 0 |
| 196 | 4 | 19 | 2309 2003 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 130(12):1109-1112 Macario-Barrel A; Balguerie X; Joly P Treatment of erosive oral lichen planus with thalidomide | 0 | 0 |
| 197 | 1 | 1 | 2310 2003 ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE 130(12):1187-1187 Schmutz JL; Barbaud A; Trechot P Thalidomide: the first case with gynecomastia | 0 | 0 |
| 198 | 1 | 6 | 1053 1992 ANNALES DE MEDECINE INTERNE 143(7):479-480 LOUZIR B; OTHMANI S; GRITLI N; BEJI M; ZIDI B; MSADDEK F; BOUSSEMA E; BAHRI M ACUTE MYELOID-LEUKEMIA IN A BEHCETS-DISEASE PATIENT UNDER LONG-TERM THALIDOMIDE TREATMENT | 0 | 3 |
| 199 | 0 | 0 | 773 1982 ANNALES DE PEDIATRIE 29(1):67-69 VENENCIE PY; SAURAT JH PYODERMA GANGRENOSUM IN A CHILD - TREATMENT WITH THALIDOMIDE | 20 | 36 |
| 200 | 0 | 0 | 448 1968 ANNALES DE RADIOLOGIE-RADIOLOGIE CLINIQUE RADIOBIOLOGIE 11(5-6):R501-& HAUKE H; WEICKER H LOWER EXTREMITIES IN THALIDOMIDE EMBRYOPATHY | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 201 | 7 | 23 | 311 1965 ANNALES PAEDIATRICI 205(5):341-& KAJII T THALIDOMIDE EXPERIENCE IN JAPAN | 8 | 8 |
| 202 | 0 | 21 | 2028 2002 ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 88(4):421-424 Medeiros M; Araujo MI; Guimaraes NS; Freitas LAR; Silva TMC; Carvalho EM Therapeutic response to thalidomide in Melkersson-Rosenthal syndrome: a case report | 1 | 2 |
| 203 | 11 | 14 | 1168 1995 ANNALS OF CLINICAL BIOCHEMISTRY 32:79-83 BOUGHTON BJ; SHEEHAN TMT; WOOD J; OBRIEN D; BUTLER M; SIMPSON A; HALE KA HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC ASSAY OF PLASMA THALIDOMIDE - STABILIZATION OF SPECIMENS AND DETERMINATION OF A TENTATIVE THERAPEUTIC RANGE FOR CHRONIC GRAFT-VERSUS-HOST DISEASE | 17 | 17 |
| 204 | 2 | 5 | 2311 2003 ANNALS OF HEMATOLOGY 82(4):262-262 Ribatti A; Vacca A On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma | 0 | 0 |
| 205 | 27 | 37 | 2312 2003 ANNALS OF HEMATOLOGY 82(9):558-564 Huang SY; Tang JL; Yao M; Ko BS; Hong RL; Tsai W; Wang CH; Tien HF; Shen MC; Chen YC Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma | 0 | 0 |
| 206 | 9 | 33 | 2313 2003 ANNALS OF HEMATOLOGY 82(10):654-659 Goldschmidt H; Sonneveld P; Cremer FW; van der Holt B; Westveer P; Breitkreutz I; Benner A; Glasmacher A; Schmidt-Wolf IGD; Martin H; Hoelzer D; Ho AD; Lokhorst HM Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients | 0 | 0 |
| 207 | 18 | 31 | 2574 2004 ANNALS OF HEMATOLOGY 83(7):467-470 Witzens M; Moehler T; Neben K; Fruehauf S; Hartschuh W; Ho AD; Goldschmidt H Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide | 0 | 0 |
| 208 | 0 | 0 | 1311 1997 ANNALS OF INTERNAL MEDICINE 127(10):951-952 Vanchieri C Preparing for thalidomide's comeback | 1 | 1 |
| 209 | 13 | 25 | 1396 1998 ANNALS OF INTERNAL MEDICINE 128(6):443-+ Hamuryudan V; Mat C; Saip S; Ozyazgan Y; Siva A; Yurdakul S; Zwingenberger K; Yazici H Thalidomide in the treatment of the mucocutaneous lesions of the Behcet syndrome - A randomized, double-blind, placebo-controlled trial | 67 | 126 |
| 210 | 5 | 19 | 1397 1998 ANNALS OF INTERNAL MEDICINE 128(6):494-495 Ehrlich GE Behcet disease and the emergence of thalidomide | 4 | 19 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 211 | 1 | 3 | 2029 2002 ANNALS OF INTERNAL MEDICINE 136(9):711-711 Escudier B; Lassau N; Leborgne S; Angevin E; Laplanche A Thalidomide and venous thrombosis | 5 | 8 |
| 212 | 65 | 116 | 1808 2001 ANNALS OF MEDICINE 33(8):516-525 Ginsburg PM; Dassopoulos T; Ehrenpreis ED Thalidomide treatment for refractory Crohn's disease: a review. of the history, pharmacological mechanisms and clinical literature | 9 | 13 |
| 213 | 6 | 12 | 1486 1999 ANNALS OF ONCOLOGY 10(7):857-859 Bruera E; Neumann CM; Pituskin E; Calder K; Ball G; Hanson J Thalidomide in patients with cachexia due to terminal cancer: Preliminary report | 14 | 30 |
| 214 | 0 | 0 | 1618 2000 ANNALS OF ONCOLOGY 11:54-54 Martinelli G; Mingrone W; Alietti A; Ferrucci F; Cocorocchio E; Peccatori F; Cinieri S; Corsini C; Zucca E; Bertolini F Clinical efficacy of thalidomide in multiple myeloma (MM), myelodysplastic syndromes (MDS) and histiocytosis | 0 | 0 |
| 215 | 0 | 0 | 1619 2000 ANNALS OF ONCOLOGY 11:60-60 Gasparini G; Gilberti S; Vitale S; Arena MG; Fanelli M; Ranieri G; Gattuso D; Biondi E; Morabito A Antitumoral activity of Thalidomide in patients affected by refractory breast cancer nad recurrent high grade gliomas. | 0 | 0 |
| 216 | 0 | 0 | 1620 2000 ANNALS OF ONCOLOGY 11:96-96 Mingrone W; Alietti A; Ferrucci F; Cocorocchio E; Peccatori F; Cinieri S; Corsini C; Zucca E; Bertolini F; Martinelli G Clinical efficacy and biologic activity of thalidomide in multiple myeloma (MM), myelodysplastic syndromes (MDS) and histiocytosis. | 0 | 0 |
| 217 | 0 | 0 | 1621 2000 ANNALS OF ONCOLOGY 11:96-96 Galani E; Grigoraki V; Kiamouris C; Samantas E; Economou O; Papdimitriou C; Gika D; Anagnostopoulos N; Dimopoulos M Thalidomide and dexamethasone combination for refractory multiple myeloma. | 0 | 0 |
| 218 | 22 | 30 | 1809 2001 ANNALS OF ONCOLOGY 12(7):885-886 Thomas DA; Kantarjian HM The revitalization of thalidomide | 4 | 5 |
| 219 | 6 | 16 | 1810 2001 ANNALS OF ONCOLOGY 12(7):987-990 Bertolini F; Mingrone W; Alietti A; Ferrucci PF; Cocorocchio E; Peccatori F; Cineri S; Mancuso P; Corsini C; Burlini A; Zucca E; Martinelli G Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers | 16 | 26 |
| 220 | 5 | 13 | 1811 2001 ANNALS OF ONCOLOGY 12(7):991-995 Dimopoulos MA; Zervas K; Kouvatseas G; Galani E; Grigoraki V; Kiamouris C; Vervessou E; Samantas E; Papadimitriou C; Economou O; Gika D; Panayiotidis P; Christakis I; Anagnostopoulos N Thalidomide and dexamethasone combination for refractory multiple myeloma | 29 | 40 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 221 | 1 | 1 | 1812 2001 ANNALS OF ONCOLOGY 12(9):1333-1333 Bertolini F; Mingrone W; Alietti A; Ferrucci PF; Cocorocchio E; Peccatori F; Cinieri S; Mancuso P; Corsini C; Burlini A; Zucca E; Martinelli G Thalidomide in multiple myeloma, myelodysplastic syndromes and histiocytosis. Analysis of clinical results and of surrogate angiogenesis markers. (vol 12, pg 987, 2001) | 0 | 1 |
| 222 | 7 | 28 | 2030 2002 ANNALS OF ONCOLOGY 13(7):1029-1035 Escudier B; Lassau N; Couanet D; Angevin E; Mesrati F; Leborgne S; Garofano A; Leboulaire C; Dupouy N; Laplanche A Phase II trial of thalidomide in renal-cell carcinoma | 10 | 21 |
| 223 | 3 | 14 | 2031 2002 ANNALS OF ONCOLOGY 13(7):1116-1119 Alexanian R; Weber D; Giralt S; Delasalle K Consolidation therapy of multiple myeloma with thalidomide-dexamethasone after intensive chemotherapy | 6 | 9 |
| 224 | 4 | 6 | 2032 2002 ANNALS OF ONCOLOGY 13(10):1636-1640 Grover JK; Uppal G; Raina V The adverse effects of thalidomide in relapsed and refractory patients of multiple myeloma | 3 | 4 |
| 225 | 9 | 9 | 2314 2003 ANNALS OF ONCOLOGY 14(3):501-502 Trojan A; Chasse E; Gay B; Pichert G; Taverna C Severe hepatic toxicity due to thalidomide in relapsed multiple myeloma | 2 | 2 |
| 226 | 11 | 28 | 2575 2004 ANNALS OF ONCOLOGY 15(1):134-138 Zervas K; Dimopoulos MA; Hatzicharissi E; Anagnostopoulos A; Papaioannou A; Mitsouli C; Panagiotidis P; Korantzis J; Tzilianos M; Maniatis A; Greek Myeloma Study Grp Primary treatment of multiple myeloma with thalidomide, vincristine, liposomal doxorubicin and dexamethasone (T-VAD doxil): a phase II multicenter study | 0 | 0 |
| 227 | 3 | 3 | 2576 2004 ANNALS OF ONCOLOGY 15(1):176-177 Kasper B; Moehler T; Neben K; Ho AD; Goldschmidt H Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myeloma | 0 | 0 |
| 228 | 5 | 5 | 2577 2004 ANNALS OF ONCOLOGY 15(3):537-537 Fuente N; Mane JM; Barcelo R; Munoz A; Perez-Hoyos T; Lopez-Vivanco G Tumor lysis syndrome in a multiple myeloma treated with thalidomide | 0 | 0 |
| 229 | 27 | 34 | 2033 2002 ANNALS OF PHARMACOTHERAPY 36(3):521-525 Bessmertny O; Pham T Thalidomide use in pediatric patients | 1 | 2 |
| 230 | 10 | 33 | 2315 2003 ANNALS OF PHARMACOTHERAPY 37(4):571-576 Thompson JL; Hansen LA Thalidomide dosing in patients with relapsed or refractory multiple myelorna | 0 | 0 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 231 | 8 | 19 | 2316 2003 ANNALS OF PHARMACOTHERAPY 37(7-8):1040-1043 Kaur A; Yu SS; Lee AJ; Chiao TB Thalidomide-induced sinus bradycardia | 1 | 1 |
| 232 | 156 | 187 | 2317 2003 ANNALS OF PHARMACOTHERAPY 37(9):1307-1320 Nasca MR; Micali G; Cheigh NH; West LE; West DP Dermatologic and nondermatologic uses of thalidomide | 1 | 1 |
| 233 | 12 | 23 | 2578 2004 ANNALS OF PHARMACOTHERAPY 38(5):808-811 Sayarlioglu M; Kotan MC; Topcu N; Bayram I; Arslanturk H; Gul A Treatment of recurrent perforating intestinal ulcers with thalidomide in Behcet's disease | 0 | 0 |
| 234 | 12 | 22 | 1116 1994 ANNALS OF THE RHEUMATIC DISEASES 53(12):828-832 GARDNERMEDWIN JMM; SMITH NJ; POWELL RJ CLINICAL-EXPERIENCE WITH THALIDOMIDE IN THE MANAGEMENT OF SEVERE ORAL AND GENITAL ULCERATION IN CONDITIONS SUCH AS BEHCETS-DISEASE - USE OF NEUROPHYSIOLOGICAL STUDIES TO DETECT THALIDOMIDE NEUROPATHY | 53 | 72 |
| 235 | 5 | 14 | 1234 1996 ANNALS OF THE RHEUMATIC DISEASES 55(11):833-836 Huizinga TWJ; Dijkmans BAC; vanderVelde EA; Kraan TCTMV; Verweij CL; Breedveld FC An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis | 20 | 37 |
| 236 | 30 | 79 | 1487 1999 ANNALS OF THE RHEUMATIC DISEASES 58:107-113 Corral LG; Kaplan G Immunomodulation by thalidomide and thalidomide analogues | 13 | 18 |
| 237 | 12 | 24 | 1169 1995 ANNALS OF THORACIC SURGERY 59(2):277-282 UTHOFF K; ZEHR KJ; GAUDIN PB; KUMAR P; CHO PW; VOGELSANG G; HRUBAN RH; BAUMGARTNER WA; STUART RS THALIDOMIDE AS REPLACEMENT FOR STEROIDS IN IMMUNOSUPPRESSION AFTER LUNG TRANSPLANTATION | 16 | 18 |
| 238 | 70 | 112 | 2034 2002 ANNUAL REVIEW OF MEDICINE 53:629-657 Richardson P; Hideshima T; Anderson K Thalidomide: Emerging role in cancer medicine | 21 | 34 |
| 239 | 10 | 18 | 1235 1996 ANTI-CANCER DRUGS 7(3):339-343 Minchinton AI; Fryer KH; Wendt KR; Clow KA; Hayes MMM The effect of thalidomide on experimental tumors and metastases | 29 | 50 |
| 240 | 23 | 38 | 1622 2000 ANTI-CANCER DRUGS 11(10):787-791 Adlard JW Thalidomide in the treatment of cancer | 5 | 11 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 241 | 22 | 30 | 2318 2003 ANTI-CANCER DRUGS 14(5):331-335 Dredge K; Dalgleish AG; Marriott JB Thalidomide analogs as emerging anti-cancer drugs | 2 | 6 |
| 242 | 4 | 25 | 1236 1996 ANTICANCER RESEARCH 16(6B):3673-3677 Gutman M; Szold A; Ravid A; Lazauskas T; Merimsky O; Klausner JM Failure of thalidomide to inhibit tumor growth and angiogenesis in vivo | 16 | 23 |
| 243 | 4 | 24 | 1398 1998 ANTICANCER RESEARCH 18(6A):4409-4413 Browne WL; Wilson WR; Baguley BC; Ching LM Suppression of serum tumour necrosis factor-alpha by thalidomide does not lead to reversal of tumour vascular collapse and anti-tumour activity of 5,6-dimethylxanthenone-4-acetic acid | 5 | 13 |
| 244 | 12 | 27 | 2319 2003 ANTICANCER RESEARCH 23(3B):2405-2411 Fujii T; Tachibana M; Dhar DK; Ueda S; Kinugasa S; Yoshimura H; Kohno H; Nagasue N Combination therapy with paclitaxel and thalidomide inhibits angiogenesis and growth of human colon cancer xenograft in mice | 0 | 0 |
| 245 | 6 | 17 | 2320 2003 ANTICANCER RESEARCH 23(3B):2481-2487 Li XP; Liu XY; Wang J; Wang ZL; Jiang W; Reed E; Zhang Y; Liu YL; Li QQ Thalidomide down-regulates the expression of VEGF and bFGF in cisplatin-resistant human lung carcinoma cells | 0 | 0 |
| 246 | 4 | 22 | 1170 1995 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 39(12):2807-2809 PETERSON PK; GEKKER G; BORNEMANN M; CHATTERJEE D; CHAO CC THALIDOMIDE INHIBITS LIPOARABINOMANNAN-INDUCED UP-REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS EXPRESSION | 3 | 10 |
| 247 | 14 | 21 | 1312 1997 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 41(12):2797-2799 Piscitelli SC; Figg WD; Hahn B; Kelly G; Thomas S; Walker RE Single-dose pharmacokinetics of thalidomide in human immunodeficiency virus-infected patients | 22 | 25 |
| 248 | 11 | 23 | 1488 1999 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 43(9):2305-2306 Ridoux O; Drancourt M Lack of in vitro antimicrosporidian activity of thalidomide | 1 | 1 |
| 249 | 17 | 32 | 1623 2000 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 44(9):2286-2290 Verbon A; Juffermans NP; Speelman P; van Deventer SJH; ten Berge IJM; Guchelaar HJ; van der Poll T A single oral dose of thalidomide enhances the capacity of lymphocytes to secrete gamma interferon in healthy humans | 16 | 17 |
| 250 | 5 | 14 | 1813 2001 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 45(5):1547-1549 Juffermans NP; Verbon A; Schultz MJ; Hack CE; van Deventer SJH; Speelman P; van der Poll T Thalidomide inhibits granulocyte responses in healthy humans after ex vivo stimulation with bacterial antigens | 2 | 2 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 251 | 9 | 36 | 2035 2002 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 46(6):1887-1895 Tsenova L; Mangaliso B; Muller G; Chen Y; Freedman VH; Stirling D; Kaplan G Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis | 3 | 5 |
| 252 | 0 | 1 | 2036 2002 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 46(7):2313-2313 Tsenova L; Mangaliso B; Muller G; Chen Y; Freedman VH; Stirling D; Kaplan G Use of IMiD3, a thalidomide analog, as an adjunct to therapy for experimental tuberculous meningitis (vol 46, pg 1889, 2002) | 0 | 0 |
| 253 | 14 | 24 | 2321 2003 ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 47(8):2445-2449 Giamarellos-Bourboulis EJ; Poulaki H; Kostomitsopoulos N; Dontas I; Perrea D; Karayannacos PE; Giamarellou H Effective immunomodulatory treatment of Escherichia coli experimental sepsis with thalidomide | 0 | 1 |
| 254 | 29 | 91 | 2579 2004 ANTIOXIDANTS & REDOX SIGNALING 6(1):1-14 Hansen JM; Harris C A novel hypothesis for thalidomide-induced limb teratogenesis: Redox misregulation of the NF-kappa B pathway | 0 | 0 |
| 255 | 7 | 17 | 2322 2003 APMIS 111:113-116 Chew M; Zhou J; Daugherty A; Eriksson T; Ellermann-Eriksen S; Hansen PR; Falk E Thalidomide inhibits early atherogenesis in apoE-deficient mice | 0 | 0 |
| 256 | 8 | 29 | 610 1975 ARCHIV DER PHARMAZIE 308(11):863-868 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .6. BIOLOGIC HALF-LIFE OF THALIDOMIDE-LIKE COMPOUND K-2004 | 2 | 6 |
| 257 | 7 | 19 | 617 1976 ARCHIV DER PHARMAZIE 309(1):62-69 PISCHEK G; KOCH H THALIDOMIDE ANALOGS .7. METABOLISM AND ELIMINATION IN RAT OF THALIDOMIDE-LIKE COMPOUND K-2004 | 1 | 3 |
| 258 | 8 | 25 | 640 1977 ARCHIV DER PHARMAZIE 310(11):917-924 PISCHEK G; FIEBRICH F; KOCH H THALIDOMIDE ANALOGS .9. BLOOD LEVEL COURSE AND ORGAN DISTRIBUTION OF BIGLUMIDE (K-2004) IN MOUSE | 0 | 2 |
| 259 | 5 | 16 | 663 1978 ARCHIV DER PHARMAZIE 311(9):779-785 PISCHEK G; FIEBRICH F; KOCH H THALIDOMIDE ANALOGS, .10. TRANSPLACENTAL DISTRIBUTION KINETICS OF BIGLUMIDE IN MOUSE | 0 | 3 |
| 260 | 2 | 15 | 718 1980 ARCHIV DER PHARMAZIE 313(6):481-487 FICKENTSCHER K; HALFMANN U; KOHLER F SYNTHESIS AND TERATOGENIC ACTIVITY OF SOME THALIDOMIDE ANALOGOUS INDANE-1,3-DIONES | 5 | 5 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 261 | 2 | 10 | 955 1988 ARCHIV DER PHARMAZIE 321(6):371-373 KOCH HP; STEINACKER C IMPROVEMENT OF SOLUBILITY AND STABILITY OF THALIDOMIDE BY INCLUSION COMPLEXATION WITH CYCLODEXTRINS | 2 | 4 |
| 262 | 0 | 2 | 956 1988 ARCHIV DER PHARMAZIE 321(9):577-577 EGER K; BOLEWSKI J; FOLKERS G; GUTBROD O; JALALIAN M; VERSPOHL E; LUPKE NP ALPHA-PHTHALIMIDOADIPINIMIDE - SYNTHESIS, TERATOGENIC PROPERTIES AND EFFECT ON THE CENTRAL NERVOUS-SYSTEM OF A HOMO-THALIDOMIDE | 0 | 0 |
| 263 | 0 | 0 | 957 1988 ARCHIV DER PHARMAZIE 321(9):602-602 HESS HR; BLASCHKE G HYDROXYLATION, A STEP IN THALIDOMIDE METABOLIZATION | 0 | 0 |
| 264 | 3 | 17 | 987 1989 ARCHIV DER PHARMAZIE 322(8):499-505 KNABE J; OMLOR G SYNTHESES OF THE RACEMATES AND THE ENANTIOMERS OF ANALOGS OF THALIDOMIDE ALKYLATED IN 3-POSITION AND DETERMINATION OF THEIR ABSOLUTE-CONFIGURATION | 2 | 4 |
| 265 | 8 | 26 | 1399 1998 ARCHIV DER PHARMAZIE 331(1):7-12 Teubert U; Zwingenberger K; Wnendt S; Eger K 5 '-substituted thalidomide analogs as modulators of TNF-alpha | 10 | 10 |
| 266 | 0 | 0 | 549 1972 ARCHIV DER PHARMAZIE UND BERICHTE DER DEUTSCHEN PHARMAZEUTISCHEN GESSELSCHAFT 305(1):77-& FICKENTS.K SYNTHESIS OF NEW THALIDOMIDE ANALOGS | 0 | 0 |
| 267 | 0 | 0 | 496 1970 ARCHIV FUR KLINISCHE UND EXPERIMENTELLE DERMATOLOGIE 237(1):312-& SHESKIN J; SAGHER F CURRENT STATUS OF THALIDOMIDE TREATMENT OF LEPROSY AND LEPRA REACTIONS | 2 | 5 |
| 268 | 10 | 16 | 2323 2003 ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX 96(10):1006-1010 Jego C; Barbou F; Laurent P; Gisserot O; Cellarier G; Bonal J; Bouchiat C; Landais C; de Jaureguiberry JP; Dussarat GV Left atrial thrombus in the course of multiple myeloma treated with thalidomide | 0 | 0 |
| 269 | 7 | 41 | 188 1963 ARCHIVES FRANCAISES DE PEDIATRIE 20(10):1242-& RAVAILLE G; MAUER ML; METZ J PREMIER CAS DEMBRYOPATHIE A LA THALIDOMIDE ETUDIE EN FRANCE | 0 | 0 |
| 270 | 9 | 54 | 514 1971 ARCHIVES INTERNATIONALES DE PHARMACODYNAMIE ET DE THERAPIE 194(1):39-& LOCKER D; SUPERSTI.E; SULMAN FG MECHANISM OF PUSH AND PULL PRINCIPLE .8. ENDOCRINE EFFECTS OF THALIDOMIDE AND ITS ANALOGUES | 4 | 4 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 271 | 1 | 8 | 719 1980 ARCHIVES OF DERMATOLOGICAL RESEARCH 269(3):275-280 FAURE M; THIVOLET J; GAUCHERAND M INHIBITION OF PMN LEUKOCYTES CHEMOTAXIS BY THALIDOMIDE | 56 | 66 |
| 272 | 0 | 0 | 741 1981 ARCHIVES OF DERMATOLOGICAL RESEARCH 270(2):229-229 KNOP J; HAPPLE R; VAKILZADEH F; MACHER E TREATMENT OF LUPUS-ERYTHEMATOSUS PROFUNDUS WITH THALIDOMIDE | 11 | 13 |
| 273 | 5 | 8 | 742 1981 ARCHIVES OF DERMATOLOGICAL RESEARCH 271(2):165-170 KNOP J; HAPPLE R; BONSMANN G; VAKILZADEH F; MACHER E TREATMENT OF CHRONIC DISCOID LUPUS-ERYTHEMATOSUS WITH THALIDOMIDE | 16 | 17 |
| 274 | 6 | 25 | 774 1982 ARCHIVES OF DERMATOLOGICAL RESEARCH 274(3-4):363-367 MIYACHI Y; OZAKI M; UCHIDA K; NIWA Y EFFECTS OF THALIDOMIDE ON THE GENERATION OF OXYGEN INTERMEDIATES BY ZYMOSAN-STIMULATED NORMAL POLYMORPHONUCLEAR LEUKOCYTES | 13 | 21 |
| 275 | 9 | 25 | 1117 1994 ARCHIVES OF DERMATOLOGICAL RESEARCH 286(6):347-349 TSAMBAOS D; BOLSEN K; GEORGIOU S; MONASTIRLI A; GOERZ G EFFECTS OF ORAL THALIDOMIDE ON RAT-LIVER AND SKIN MICROSOMAL P450 ISOZYME ACTIVITIES AND ON URINARY PORPHYRIN EXCRETION - INTERACTION WITH ORAL HEXACHLOROBENZENE | 14 | 15 |
| 276 | 0 | 0 | 690 1979 ARCHIVES OF DERMATOLOGY 115(5):636-637 MASCARO JM; LECHA M; TORRAS H THALIDOMIDE IN THE TREATMENT OF RECURRENT, NECROTIC, AND GIANT MUCOCUTANEOUS APHTHAE AND APHTHOSIS | 64 | 78 |
| 277 | 7 | 10 | 720 1980 ARCHIVES OF DERMATOLOGY 116(5):571-572 VANDENBROEK H TREATMENT OF PRURIGO NODULARIS WITH THALIDOMIDE | 35 | 48 |
| 278 | 2 | 4 | 775 1982 ARCHIVES OF DERMATOLOGY 118(8):536-536 SAYLAN T; SALTIK I THALIDOMIDE IN THE TREATMENT OF BEHCETS SYNDROME | 42 | 58 |
| 279 | 0 | 2 | 776 1982 ARCHIVES OF DERMATOLOGY 118(11):875-875 TORRAS H; LECHA M; MASCARO JM THALIDOMIDE TREATMENT OF RECURRENT NECROTIC GIANT MUCOCUTANEOUS APHTHAE AND APHTHOSIS | 18 | 24 |
| 280 | 18 | 25 | 800 1983 ARCHIVES OF DERMATOLOGY 119(10):812-815 HASPER MF CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS - THALIDOMIDE TREATMENT OF 11 PATIENTS | 21 | 32 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 281 | 6 | 20 | 842 1984 ARCHIVES OF DERMATOLOGY 120(3):338-341 CLEMMENSEN OJ; OLSEN PZ; ANDERSEN KE THALIDOMIDE NEUROTOXICITY | 41 | 59 |
| 282 | 17 | 35 | 843 1984 ARCHIVES OF DERMATOLOGY 120(11):1466-1470 ARONSON IK; YU R; WEST DP; VANDENBROEK H; ANTEL J THALIDOMIDE-INDUCED PERIPHERAL NEUROPATHY - EFFECT OF SERUM FACTOR ON NERVE CULTURES | 34 | 38 |
| 283 | 21 | 26 | 1004 1990 ARCHIVES OF DERMATOLOGY 126(7):923-927 REVUZ J; GUILLAUME JC; JANIER M; HANS P; MARCHAND C; SOUTEYRAND P; BONNETBLANC JM; CLAUDY A; DALLAC S; KLENE C; CRICKX B; SANCHOGARNIER H; CHAUMEIL JC CROSSOVER STUDY OF THALIDOMIDE VS PLACEBO IN SEVERE RECURRENT APHTHOUS STOMATITIS | 53 | 100 |
| 284 | 29 | 41 | 1084 1993 ARCHIVES OF DERMATOLOGY 129(10):1261-1264 THOMAS L; DUCROS B; SECCHI T; BALME B; MOULIN G SUCCESSFUL TREATMENT OF ADULTS LANGERHANS CELL HISTIOCYTOSIS WITH THALIDOMIDE - REPORT OF 2 CASES AND LITERATURE-REVIEW | 23 | 40 |
| 285 | 9 | 13 | 1085 1993 ARCHIVES OF DERMATOLOGY 129(12):1548-1550 HOLM AL; BOWERS KE; MCMEEKIN TO; GASPARI AA CHRONIC CUTANEOUS LUPUS-ERYTHEMATOSUS TREATED WITH THALIDOMIDE | 16 | 19 |
| 286 | 19 | 23 | 1118 1994 ARCHIVES OF DERMATOLOGY 130(1):66-69 OCHONISKY S; VERROUST J; BASTUJIGARIN S; GHERARDI R; REVUZ J THALIDOMIDE NEUROPATHY INCIDENCE AND CLINICOELECTROPHYSIOLOGIC FINDINGS IN 42 PATIENTS | 72 | 95 |
| 287 | 9 | 19 | 1171 1995 ARCHIVES OF DERMATOLOGY 131(9):1032-1035 GUILLAUME JC; MOULIN G; DIENG MT; POLI F; MOREL P; SOUTEYRAND P; BONNETBLANC JM; CLAUDY A; DANIEL F; VAILLANT L; BERNARD P; BOUILLIE MC; BOURNERIAS I; DENOEUX JP; LAMBERT D; LEONARD F; CHAUMEIL JC; REVUZ J CROSSOVER STUDY OF THALIDOMIDE VS PLACEBO IN JESSNERS LYMPHOCYTIC INFILTRATION OF THE SKIN | 12 | 17 |
| 288 | 2 | 3 | 1237 1996 ARCHIVES OF DERMATOLOGY 132(11):1392-1393 Dereure O; BassetSeguin N; Guilhou JJ Erosive lichen planus: Dramatic response to thalidomide | 14 | 24 |
| 289 | 4 | 5 | 1400 1998 ARCHIVES OF DERMATOLOGY 134(8):1045-1046 Rousseau L; Beylot-Barry M; Doutre MS; Beylot C Cutaneous sarcoidosis successfully treated with low doses of thalidomide | 12 | 25 |
| 290 | 44 | 53 | 1489 1999 ARCHIVES OF DERMATOLOGY 135(9):1079-1087 Duong DJ; Spigel GT; Moxley RT; Gaspari AA American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus | 19 | 28 |
| # | LCR | NCR | Nodes / Date / Journal / Authors | LCS | GCS |
| 291 | 4 | 4 | 1624 2000 ARCHIVES OF DERMATOLOGY 136(12):1442-1443 Camisa C; Popovsky JL Effective treatment of oral erosive lichen planus with thalidomide | 6 | 11 |
| 292 | 11 | 30 | 2324 2003 ARCHIVES OF DERMATOLOGY 139(1):50-54 Housman TS; Jorizzo JL; McCarty MA; Grummer SE; Fleischer AB; Sutej PG Low-dose thalidomide therapy for refractory cutaneous lesions of lupus erythematosus | 2 | 3 |
| 293 | 16 | 25 | 2325 2003 ARCHIVES OF DERMATOLOGY 139(2):136-138 Thomas P; Walchner M; Ghoreschi K; Rocken M Successful treatment of granulomatous cheilitis with thalidomide | 0 | 0 |
| 294 | 10 | 44 | 2580 2004 ARCHIVES OF DERMATOLOGY 140(3):277-280 Caradona S; Jacobe H Thalidomide as a potential treatment for scleromyxedema | 0 | 0 |
| 295 | 30 | 47 | 2581 2004 ARCHIVES OF DERMATOLOGY 140(7):845-849 Maurer T; Poncelet A; Berger T Thalidomide treatment for prurigo nodularis in human immunodeficiency virus-infected subjects - Efficacy and risk of neuropathy | 0 | 0 |
| 296 | 3 | 13 | 312 1965 ARCHIVES OF DISEASE IN CHILDHOOD 40(210):154-& MAIER WA THALIDOMIDE EMBRYOPATHY AND LIMB DEFECTS - EXPERIENCES IN HABILITATION OF CHILDREN WITH ECTROMELIAS | 0 | 1 |
| 297 | 0 | 0 | 497 1970 ARCHIVES OF DISEASE IN CHILDHOOD 45(240):274-& SMITHELL.RW HAND AND FOOT PREFERENCE IN THALIDOMIDE CHILDREN | 0 | 2 |
| 298 | 4 | 5 | 1238 1996 ARCHIVES OF DISEASE IN CHILDHOOD 74(1):64-65 Soler RA; Migliorati C; vanWaes H; Nadal D Thalidomide treatment of mucosal ulcerations in HIV infection | 11 | 14 |
| 299 | 1 | 2 | 1239 1996 ARCHIVES OF DISEASE IN CHILDHOOD 75(1):90-90 Harry TC Thalidomide treatment of mucosal ulcerations in HIV infection | 0 | 0 |
| 300 | 6 | 14 | 53 1962 ARCHIVES OF ENVIRONMENTAL HEALTH 5(2):100-& LENZ W; KNAPP K THALIDOMIDE EMBRYOPATHY | 10 | 62 |
Page 1: 1 2 3 4 5 6 7 8 9
Generated by: HistCite(Vlad).
Version: 2004.09.22